Association between High-Sensitivity C-Reactive Protein and N-Terminal Pro-B-Type Natriuretic Peptide in Patients with Hepatitis C Virus Infection

Table 4

Echocardiographic measurements between groups.

Variables	Patients (𝑁=106)	Controls (𝑁=106)	𝑃 value
LVDd (mm)	48.23±4.31	47.87±3.54	0.507
LVPWd (mm)	9.46±1.73	9.13±1.82	0.177
IVSd (mm)	9.75±1.66	9.82±1.45	0.744
E (cm/s) *	69.84±13.43	87.54±16.27	<0.01
A (cm/s)	62.13±10.37	59.84±11.32	0.126
E/A^∗	1.13±0.34	1.47±0.41	<0.01
DT (ms)	175.4±26.7	177.4±24.9	0.573
E^′ (cm/s)*	7.28±2.42	9.83±2.74	<0.01
A^′ (cm/s)	10.51±2.84	9.98±2.94	0.183
E/E^′∗	9.77±2.45	8.86±2.74	0.012
LVEF (%)	64.73±7.45	66.46±7.73	0.099
FS (%)	38.54±4.62	39.15±4.82	0.348

Abbreviations: LVDd, left ventricular diastolic diameter; LVPWd, left ventricular posterior wall diastolic thickening; IVSd, interventricular septum diastolic thickening; E, peak early diastolic transmitral flow; A, peak late diastolic transmitral flow; E^′, peak early diastolicannular velocity; A^′, peak late diastolic annular velocity; E/E^′, the ratio of E to E^′; DT, deceleration time; LVEF, left ventricular ejection fraction; FS, fractional shortening
Data are expressed as mean ± SD.
*A P value of less than 0.05 was considered statistically significant.